Quick Answer
SELECT MEDICAL HOLDINGS CORP reported Total Revenue of $5.45 billion for fiscal year 2025.
SELECT MEDICAL HOLDINGS CORP — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Revenue | $5.45B +5.1% |
$5.19B +7.5% |
$4.83B +4.7% |
$4.61B -25.7% |
$6.20B +12.2% |
$5.53B +1.4% |
| Revenue (ASC 606) | $5.45B +5.1% |
$5.19B +7.5% |
$4.83B +4.7% |
$4.61B -25.7% |
$6.20B +12.2% |
$5.53B +1.4% |
| Net Income | $146.22M -31.7% |
$214.04M -12.1% |
$243.49M +53.1% |
$158.99M -60.5% |
$402.23M +55.3% |
$259.00M +74.5% |
| Diluted EPS | $1.16 -30.1% |
$1.66 -13.1% |
$1.91 +55.3% |
$1.23 -58.7% |
$2.98 +54.4% |
$1.93 +75.5% |
| Total Assets | $5.85B +4.3% |
$5.61B -27.1% |
$7.69B +0.3% |
$7.67B +4.1% |
$7.36B -3.9% |
$7.66B +4.3% |
| Cash and Equivalents | $26.52M -55.6% |
$59.69M +13.4% |
$52.63M -46.2% |
$97.91M +31.8% |
$74.31M -87.1% |
$577.06M +71.8% |
| Long-Term Debt | — | — | — | — | — | — |
| Stockholders Equity | $1.71B +1.4% |
$1.68B +30.5% |
$1.29B +14.8% |
$1.12B +1.1% |
$1.11B +4.7% |
$1.06B +37.6% |
| Operating Income | $336.17M +25.3% |
$268.31M +0.4% |
$267.24M +84.6% |
$144.75M -79.7% |
$713.77M +25.7% |
$567.66M +20.3% |
| Shares Outstanding | 124.02M -3.8% |
128.96M +0.5% |
128.37M +0.9% |
127.17M -5.0% |
133.88M -0.7% |
134.85M +0.4% |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | September 30, 2025 | $1.36B | +7.2% | +1.8% |
| Revenue (ASC 606) | September 30, 2025 | $1.36B | +7.2% | +1.8% |
| Net Income | September 30, 2025 | $28.79M | -48.2% | -29.0% |
| Diluted EPS | September 30, 2025 | $0.23 | -46.5% | -28.1% |
| Total Assets | September 30, 2025 | $5.69B | -29.0% | -1.0% |
| Cash and Equivalents | September 30, 2025 | $60.05M | -68.6% | +14.7% |
| Long-Term Debt | June 30, 2015 | $2.43B | +52.1% | +54.9% |
| Stockholders Equity | September 30, 2025 | $1.69B | -11.8% | +1.3% |
| Operating Income | September 30, 2025 | $72.96M | +32.9% | -15.7% |
| Shares Outstanding | September 30, 2025 | 123.82M | -4.4% | +0.8% |
- SELECT MEDICAL HOLDINGS CORP reported Total Revenue of $5.45 billion for fiscal year 2025.
- SELECT MEDICAL HOLDINGS CORP showed an increase of +5.1% in Total Revenue compared to the prior fiscal year.
- SELECT MEDICAL HOLDINGS CORP reported Revenue (ASC 606) of $5.45 billion for fiscal year 2025.
- SELECT MEDICAL HOLDINGS CORP showed an increase of +5.1% in Revenue (ASC 606) compared to the prior fiscal year.
- SELECT MEDICAL HOLDINGS CORP reported Net Income of $146.22 million for fiscal year 2025.
- SELECT MEDICAL HOLDINGS CORP showed a decrease of -31.7% in Net Income compared to the prior fiscal year.
- SELECT MEDICAL HOLDINGS CORP reported Diluted EPS of $1.16 per share for fiscal year 2025.
- SELECT MEDICAL HOLDINGS CORP showed a decrease of -30.1% in Diluted EPS compared to the prior fiscal year.
- SELECT MEDICAL HOLDINGS CORP reported Total Assets of $5.85 billion for fiscal year 2025.
- SELECT MEDICAL HOLDINGS CORP showed an increase of +4.3% in Total Assets compared to the prior fiscal year.
- SELECT MEDICAL HOLDINGS CORP reported Cash and Equivalents of $26.52 million for fiscal year 2025.
- SELECT MEDICAL HOLDINGS CORP showed a decrease of -55.6% in Cash and Equivalents compared to the prior fiscal year.
- SELECT MEDICAL HOLDINGS CORP reported Long-Term Debt of $1.54 billion for fiscal year 2014.
- SELECT MEDICAL HOLDINGS CORP showed an increase of +8.0% in Long-Term Debt compared to the prior fiscal year.
- SELECT MEDICAL HOLDINGS CORP reported Stockholders Equity of $1.71 billion for fiscal year 2025.
- SELECT MEDICAL HOLDINGS CORP showed an increase of +1.4% in Stockholders Equity compared to the prior fiscal year.
- SELECT MEDICAL HOLDINGS CORP reported Operating Income of $336.17 million for fiscal year 2025.
- SELECT MEDICAL HOLDINGS CORP showed an increase of +25.3% in Operating Income compared to the prior fiscal year.
- SELECT MEDICAL HOLDINGS CORP reported Shares Outstanding of 124.02 million shares for fiscal year 2025.
- SELECT MEDICAL HOLDINGS CORP showed a decrease of -3.8% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: